|
MedChemExpress
ikk 16 Ikk 16, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ikk-16/IKK+16/pm42471442-186-20-23 Average 95 stars, based on 1 article reviews
ikk 16 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
MedChemExpress
ikk16 ![]() Ikk16, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ikk-16/IKK+16/bio_rxiv__64898__2026__06__24__734137-49-16-19 Average 95 stars, based on 1 article reviews
ikk16 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
MedChemExpress
lrrk2 inhibitor ikk16 ![]() Lrrk2 Inhibitor Ikk16, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ikk-16/IKK+16/pm41881967-57-0-13 Average 95 stars, based on 1 article reviews
lrrk2 inhibitor ikk16 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
MedChemExpress
e2920 ikk16 mce ![]() E2920 Ikk16 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ikk-16/IKK+16/pm41638206-219-144-146 Average 95 stars, based on 1 article reviews
e2920 ikk16 mce - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: Multi-omics Profiling Reveals an NF-κB-Driven Anti-apoptotic Network Underlying Resistance to Oncolytic VSV in Prostate Cancer Cells
doi: 10.64898/2026.06.24.734137
Figure Lengend Snippet: Inhibition of the anti-apoptotic BCL-2 and NF-κB pathways restores sensitivity to VSV infection in PC3 cellsPC3 cells were exposed to selective BCL-2 pathway inhibitors (ABT-199 and ABT-737) or a selective NF-κB pathway inhibitor (IKK16) either alone, or in the presence of VSV infection (at an MOI of 50, using either wild-type virus or the attenuated R1 mutant). Cell survival was then quantitated using the PrestoBlue cell viability assay at 24 post-treatment with each drug. Viral infection was initiated 8 h prior to analysis at each timepoint. Data represent the mean ± SEM of 3 biological replicates. **** p < 0.0001, *** p < 0.001, ** p < 0.01 (Student’s t -test).
Article Snippet: Cells were treated with 5 μM of ABT-199, 5 μM of ABT-737, or 10 μM of
Techniques: Inhibition, Infection, Virus, Mutagenesis, Viability Assay